Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770470 · ClinicalTrials.gov registry record
Chitosan Chewing Gum Study in Dialysis Patients
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 15
- Enrollment target
NCT01770470: Completed study, sponsored by University of Maryland, Baltimore.
NCT01770470 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01770470 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.
Primary Outcome
Serum phosphate will be drawn 3 times per week over 2 weeks (during gum therapy), then once at 4 weeks and once at 6 weeks.
Interventions
- DIETARY_SUPPLEMENT Chitosan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-01 |
What the finished NCT01770470 record still lists
NCT01770470 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Chitosan is the first listed.
NCT01770470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01770470 about?
NCT01770470 is a clinical study titled "Chitosan Chewing Gum Study in Dialysis Patients". The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.
What is the current status of trial NCT01770470?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2010-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01770470?
The interventions under investigation include: Chitosan (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01770470?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia